Publications by authors named "Dawn Torres"

Claim this Profile
I
Infliximab-induced autoimmune hepatitis.
Alexander Jenkins, Amy Austin, Kathryn Hughes, Brett Sadowski, Dawn Torres

BMJ Case Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilson's Disease and Iron Overload: Pathophysiology and Therapeutic Implications.
Kevin Pak, Sarah Ordway, Brett Sadowski, Margaux Canevari, Dawn Torres

Clin Liver Dis (Hoboken)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occult HBV Infection: A Case Series at a Military Treatment Facility.
Kevin Pak, Sarah Ordway, Dawn Torres

Mil Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
John Shumar, Sarah Ordway, Zachary Junga, Brett Sadowski, Dawn Torres

ACG Case Rep J· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jaundice in a Service member Returning From Taiwan; Diagnostic Challenges in a Case of Acute Hepatitis E.
Allison Bush, Brett Sadowski, Dawn Torres

Mil Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: FibroTest to predict liver-related mortality in NAFLD. Should this change the diagnostic algorithm in NAFLD?
Allison M Bush, Dawn M Torres

Aliment Pharmacol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials.
William N Hannah, Dawn M Torres, Stephen A Harrison

Gastroenterol Hepatol (N Y)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C eradication with sofosbuvir leads to significant metabolic changes.
Amilcar L Morales, Zachary Junga, Manish B Singla, Maria Sjogren, Dawn Torres

World J Hepatol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
Dawn M Torres, Stephen A Harrison

Hepatology· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, controlled pilot study comparing large-volume paracentesis using wall suction and traditional glass vacuum bottle methods.
Monica A Konerman, Jennifer Price, Dawn Torres, Zhiping Li

Therap Adv Gastroenterol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutrition in cirrhosis and chronic liver disease.
Wassem Juakiem, Dawn M Torres, Stephen A Harrison

Clin Liver Dis· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of treatment options for nonalcoholic fatty liver disease.
Richele L Corrado, Dawn M Torres, Stephen A Harrison

Med Clin North Am· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?
Ryan M Kwok, Dawn M Torres, Stephen A Harrison

Hepatology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive methods of assessing nonalcoholic fatty liver disease: what the clinician needs to know.
Dawn M Torres, Stephen A Harrison

Clin Gastroenterol Hepatol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis.
Dawn M Torres, Stephen A Harrison

Nat Rev Gastroenterol Hepatol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small steps toward a better treatment for chronic hepatitis C infection: mericitabine, pegylated interferon, and ribavirin in the PROPEL and JUMP-C trials.
Dawn M Torres, Stephen A Harrison

Hepatology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial.
Carly Eckard, Renee Cole, Joshua Lockwood, Dawn M Torres, Christopher D Williams

Therap Adv Gastroenterol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killing two birds with one stone: screening for chronic hepatitis C at the time of colonoscopy in the baby boomer cohort.
Dawn M Torres, Stephen A Harrison

Am J Gastroenterol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it time to write a prescription for coffee? Coffee and liver disease.
Dawn M Torres, Stephen A Harrison

Gastroenterology· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle.
Dawn M Torres, Stephen A Harrison

Hepatology· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical activity: an essential component of lifestyle modification in NAFLD.
Benjamin Rodriguez, Dawn M Torres, Stephen A Harrison

Nat Rev Gastroenterol Hepatol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exercise.
Angelo H Paredes, Dawn M Torres, Stephen A Harrison

Clin Liver Dis (Hoboken)· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Features, diagnosis, and treatment of nonalcoholic fatty liver disease.
Dawn M Torres, Christopher D Williams, Stephen A Harrison

Clin Gastroenterol Hepatol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic fatty liver disease.
Angelo H Paredes, Dawn M Torres, Stephen A Harrison

Clin Liver Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil.
Dawn M Torres, Stephen A Harrison

Semin Liver Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis